In the model including “known cancer < 5 years prior to stroke”, sex, mRS on admission, history of venous thromboembolism, hemoglobin, and platelet count (data for all co-variables available for 651 patients within the study cohort of 753 patients), risk for death was associated with known cancer (HR 1.7), low hemoglobin (HR 2.6), mRS on admission ≥ 4 (HR 1.9), pathologic platelet count (HR 1.6), female sex (HR 1.7), and elevated CRP (HR 1.4), while history of venous thromboembolism was not. The gene discussed is CRP; the disease is venous thromboembolism.